SOURCE: Calabrian Corporation

Calabrian Corporation

September 25, 2014 13:45 ET

Calabrian Announces SO2 Price Increase

HOUSTON, TX--(Marketwired - Sep 25, 2014) - Calabrian Corporation, the largest prime producer of liquid sulfur dioxide and related derivatives in North America, announced that effective Oct. 15, or when permissible by contract, it will increase the price of sulfur dioxide by $100 per short ton. The increase is reflective of the sulfur dioxide market, which has tightened considerably, as a result of strong demand and reduced availability of byproduct material.

"This price increase will support our continued investment in our SO2 and derivatives business," said Jeffrey Hammerstrom, director of business development. "Our expansion of SO2 production will enable Calabrian to provide our customers with a reliable, on purpose, source of sulfur dioxide to meet their needs and allow Calabrian to strengthen its market leading position in SO2, sodium metabisulfite, and other sulfur derivatives."

In July, Calabrian announced plans to expand production of SO2 at its Port Neches, Texas, plant. The multimillion-dollar expansion, using the company's proprietary SO2Clean technology, is expected to be online by the end of the year.

Calabrian Corporation is a leading supplier of sulfur dioxide and related derivatives used in wastewater treatment and other applications. The company manufactures sulfur dioxide and downstream derivatives such as sodium bisulfite solution, sodium metabisulfite, sodium thiosulfate, and sodium sulfite solution. Its products are used in a broad range of industrial and municipal wastewater treatment applications to achieve compliance with federal and local water regulations, as well as other specialty applications in personal care, pulp and paper processing, food preservation, oilfield production, mining, and disinfection. For more information please visit

Calabrian Corporation is a portfolio company of SK Capital Partners. SK Capital Partners is a private investment firm with a disciplined focus on the specialty materials, chemicals, and healthcare sectors. The firm utilizes its industry, operating, and investment experience to help transform businesses into higher performing organizations. Headquartered in New York, NY, SK Capital's portfolio companies generate revenues of approximately $6.5 billion annually and employ more than 8,700 people. For more information please visit

Contact Information